Wound Care Biologics Market

Preliminary research of Fairfield Market Research indicates a promising growth outlook for global wound care biologics market during the course of next few years.

Increasing Prevalence of Diseases and Conditions to Augment Growth for the Wound Care Biologics Market

There has been a steady increase in the prevalence of diseases and other conditions around the world for reasons such as booming geriatric populations, a greater number of surgeries being undertaken, and a spike in the number of wounds being treated globally. For example, diabetes can increase the likelihood of developing or being more susceptible to various infections, lesions, chronic wounds, and ulcerations. This has led to a greater need for effective wound care solutions, thus contributing to the overall growth of the global wound care biologics market.

Wound care biologics are treatment products that are derived from living organisms or cells. Advancements in wound care technology have led to the introduction of biotechnology in wound care.

High Costs Could Potentially Hinder Wound Care Biologics Market Growth Prospects in Long Term

Chronic wound therapies and wound care biologics general are high in cost. Despite the availability of bioengineered products, cost is a major factor that will act as an adoption deterrent among both medical professionals and patients alike, who would instead opt for conventional wound care solutions. This is expected to have a negative impact on the growth trajectory of wound care biologics market, particularly in cost-sensitive economies.

Wound Care Biologics Market: COVID-19 Impact

With the onset of the COVID-19 pandemic, the imposing of restrictions by respective governments on the movement of people and goods, as well as the hampered supply of necessary raw materials, among other operational hurdles, resulted in a significant decline in generated revenues for several industries. This was no different for the wound care biologics market. Due to several comorbidities, wound patients are more likely to experience serious impacts of COVID-19. This acted as a major element that led to a decline in market growth for the short-term. However, as restrictions were gradually relaxed, post the 3^rd and 4^th waves, this global market regressed to its pre-COVID state of operations.

Increasing Investments Channelizing Toward Innovations Will Expedite Wound Care Biologics Market

Increased investments by respective governments for the development of more innovative wound care products and procedures is a crucial factor augmenting revenue growth prospects for this global market. Moreover, higher expenditure towards improving healthcare infrastructure, a greater demand for broader healthcare provisions, and the overall increasing cost of healthcare are also elements contributing to the expansion of the wound care biologics market.

North America’s Wound Care Biologics Market Continues to be in the Bandwagon as Chronic and Lifestyle-related Conditions Prevail

Owing to the vast number of diabetic patients who are more susceptible to chronic wounds, as well as an increase in the number of individuals suffering from lifestyle-related diseases, North America’s wound care biologics market remains at the forefront. Moreover, improving standards of living and higher disposable incomes are a few other factors contributing to the dominance of this region in the global market space. The market in Asia Pacific is also slated to index significant growth over the forecast period while the key European markets like Germany, and the United Kingdom are expected to emerge as lucrative pockets of potential investors.

Wound Care Biologics Market: Competitive Landscape              

Major players in the global wound care biologics market include Smith & Nephew, Mölnlycke Health Care, Integra Lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, MIMEDX Group, and Solsys Medical. To gain a competitive edge, various established industry players are now more focused on new product launches, partnerships, collaborations, acquisitions, and alliances.

Recent Notable Developments

• In April 2021, Kerecis launched its Kerecis Omega3 GraftGuide, an intact fish skin that uniquely addresses the challenges of burn healing
  
  
• In May 2022, MIMEDX received a US$4.6 million grant to evaluate PURION processed Dehydrated Human Amnion Chorion Membrane (DHACM) from the Department of Defense to advance the treatment of combat casualty wounds and burns
  
  
• In January 2021, Integra LifeSciences completed the acquisition of ACell Inc. This enabled Integra to offer more comprehensive and complex wound management solutions
  
  
• In June 2021, MIMEDX received approval from the Japanese Ministry of Health, Labour and Welfare for the commercialization of Epifix
  
  
• In July 2022, Tides Medical, a biologics company, launched Artacent AC, a tri-layer skin graft product designed for use in the treatment of complex or difficult-to-treat wounds

Regional Classification of Global Wound Care Biologics Market Can be Given as Below:

North America

• U.S.
• Canada

Europe

• Germany
• France
• Spain
• U.K.
• Italy
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa

• GCC
• South Africa
• Rest of Middle East and Africa

*Regions and countries are subject to change based on data availability.

Key Elements Included In The Study: Global Wound Care Biologics Market

• Wound Care Biologics Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2019 - 2022
• Market Value at Regional and Country Level, 2023 - 2030
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2023 - 2030
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.